11/17/2026 Beth Hart
A Carle Illinois College of Medicine student is developing a new lab-on-a-chip model to study why some people with Graves’ disease develop thyroid eye disease while others do not.
Written by Beth Hart
New research led by a Carle Illinois College of Medicine student could help answer why some patients with an overactive thyroid develop eye problems while others don’t. MD/PhD candidate Bhargavee Gnana is building a unique model to fuel a holistic study of how thyroid eye disease (TED) develops and progresses in patients with Graves’ disease (autoimmune hyperthyroidism).
About half of patients with Graves’ disease also develop thyroid eye disease, causing inflammation in the connective tissue around the eye. These patients may have bulging eyes, pressure, itching, and double vision. If left untreated, thyroid eye disease can result in permanent damage. But scientists now know little about how the disease develops or what factors influence its progression.
“One of the biggest challenges that we face for patients who have thyroid eye disease is that there are not very good models to study how the disease actually comes about. Current research is dependent on human tissue samples and makes the disease hard to study,” Gnana said. “Previous studies have used patient-derived orbital fibroblasts –– the cells that help build the tissue around the eye –– to investigate individual molecular pathways. Our project builds on that work by creating a system designed to model communication among orbital fibroblasts, immune cells, and thyroid cells over time.”
With support from a $330,000 National Institutes of Health Fellowship Grant for MD/PhD candidates, Gnana is creating a ‘lab-on-a-chip’ microenvironment about the size of a credit card to study thyroid eye disease at the cellular and molecular levels. Using a microfluidic device (a system using tiny fluid molecules passed through channels the size of a human hair), Gnana will study signals from the immune system, thyroid, and connective tissue around the eye that may play a role in thyroid eye disease.
“With lab-on-a-chip, we can create a way for more researchers to use a reproducible model that can potentially provide a foundation for more work beyond just human tissue samples. It makes thyroid eye disease an accessible disorder to study,” Gnana said.
Gnana is an aspiring ophthalmologist in CI MED’s MD/PhD Medical Scholars Program. Her doctoral dissertation project in bioengineering focuses on this new approach to thyroid eye disease research, working with Dean Mark Cohen’s research lab. Cohen is a practicing surgical oncologist and endocrine surgeon who is involved in research to develop cellular therapies for endocrine disorders. Research Associate Professor and Translational Oncology and Regenerative Medicine Laboratory Director Chitra Subramanian also serves as a mentor.
Gnana is working with the University of Chicago and the University of West Virginia to obtain patient samples needed for the project.
Editor’s note:
The project, “Molecular and Cellular Characterization of Orbital Fibroblast-Immune Crosstalk in TED Using Patient-Derived Microphysiological Systems,” is funded by the Ruth L. Kirschstein National Research Service Award Fellowship (an F30 Fellowship grant) through the NIH. This prestigious fellowship covers tuition, a stipend, and research expenses for up to six years.